Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Healthcare Facilities & Services

Market Closed - Nyse 04:00:02 2024-03-28 pm EDT 5-day change 1st Jan Change
133.1 USD +1.56% Intraday chart for Quest Diagnostics Incorporated +4.22% -3.46%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Quest Diagnostics Incorporated Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 10:15 AM
Quest Diagnostics Insider Sold Shares Worth $852,769, According to a Recent SEC Filing MT
Leerink Partners Starts Quest Diagnostics With Market Perform Rating, $135 Price Target MT
Quest Diagnostics Incorporated acquired Assets from Lenco Diagnostic Laboratories Inc. for approximately $110 million. CI
Quest Diagnostics' Pack Health, Instacart to Combine Grocery Delivery With Nutrition Coaching Services MT
The fate of the market depends on this Our Logo
ANALYST RECOMMENDATIONS : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever.... Our Logo
Correction: Quest Diagnostics Participates in Freenome's $254 Million Financing MT
Quest Diagnostics Participates in Freenome's $254 Million Financing MT
Freenome Holdings, Inc. announced that it has received $254 million in funding from a group of investors CI
Quest Diagnostics Incorporated Announces the Launch of MelaNodal Predict CI
Quest Diagnostics Incorporated Announces the Availability of the First Consumer-Initiated, Physician-Ordered Blood-Draw Test for PFAS Chemicals CI
Jefferies Upgrades Quest Diagnostics to Buy From Hold, Adjusts Price Target to $155 From $140 MT
Fed officials fail to convince investors, who are focused on earnings Our Logo
ANALYST RECOMMENDATIONS : Caterpillar, Eli Lilly, Intel, Meta, T-Mobile... Our Logo
Deutsche Bank Adjusts Quest Diagnostics Price Target to $125 From $140, Maintains Hold Rating MT
Quest Diagnostics' Q4 Adjusted Earnings Increase, Revenue Declines; Issues 2024 Outlook; Raises Dividend MT
Transcript : Quest Diagnostics Incorporated, Q4 2023 Earnings Call, Feb 01, 2024
(DGX) QUEST DIAGNOSTICS Sees Fiscal Year 2024 Revenue Range $9.35B - $9.45B MT
(DGX) QUEST DIAGNOSTICS Sees Fiscal Year 2024 EPS Range $8.60 - $8.90 MT
Earnings Flash (DGX) QUEST DIAGNOSTICS Reports Q4 Revenue $2.29B, vs. Street Est of $2.25B MT
Earnings Flash (DGX) QUEST DIAGNOSTICS Posts Q4 EPS $2.15, vs. Street Est of $2.11 MT
Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010. CI
Quest Diagnostics Incorporated Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Quest Diagnostics Incorporated Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Chart Quest Diagnostics Incorporated
More charts
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows: - testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services; - other (2.7%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
133.1 USD
Average target price
141.8 USD
Spread / Average Target
+6.52%
Consensus